Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBIO Brand Development was a Vancouver-based health and wellness company focused on hemp-infused CBD consumer products rather than prescription therapeutics. Its main business centered on the Armourgenix brand, a line of sports and wellness supplements marketed with enhanced CBD absorption using a patented oligopeptide ingredient powered by GrowthCell technology. The company also pursued e-commerce distribution for CBD and wellness products, including references to the Purewerx platform and Armourgenix direct-to-consumer branding. In March 2020, CBIO Brand Development was acquired by Block X Capital, which subsequently rebranded as Brand X Lifestyle, so CBIO no longer appears to operate as an independent active company. While it sits adjacent to healthcare and wellness, it does not appear to be a traditional biotech or pharma developer with a clinical drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBIO Brand Development.